Entering text into the input field will update the search result below
Try for free
Search for Symbols, analysts, keywords

Syndax Pharmaceuticals GAAP EPS of $1.81 beats by $1.84, revenue of $126.6M beats by $67.92M

Mar. 01, 2022 4:21 PM ETSyndax Pharmaceuticals, Inc. (SNDX)By: Urvi Shah, SA News Editor
  • Syndax Pharmaceuticals press release (NASDAQ:SNDX): Q4 GAAP EPS of $1.81 beats by $1.84.
  • Revenue of $126.6M (+63200.0% Y/Y) beats by $67.92M.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.